Ying Huang
Director Ejecutivo en LEGEND BIOTECH CORPORATION .
Fortuna: 2 M $ al 31/12/2024
Perfil
En la actualidad, Ying Huang ocupa el cargo de Director Ejecutivo y Financiero de Legend Biotech Corp. En su anterior carrera, el Dr. Huang ocupó el cargo de Científico Principal en Schering-Plough Corp., Analista de Investigación en Credit Suisse Securities (USA) LLC (Broker), Analista Asociado en Wachovia Securities LLC, Vicepresidente y Analista Senior en Barclays Capital, Inc. y Analista de Investigación en Merrill Lynch, Pierce, Fenner & Smith, Inc. y Analista de Investigación en Gleacher & Co. Securities, Inc. El Dr. Huang obtuvo un doctorado y un título de posgrado en The Trustees of Columbia University en la ciudad de Nueva York y una licenciatura en la Universidad de Ciencia y Tecnología de China.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
LEGEND BIOTECH CORP.
0,04 % | 31/12/2023 | 128 492 ( 0,04 % ) | 2 M $ | 31/12/2024 |
Últimas noticias acerca de Ying Huang
Cargos activos de Ying Huang
Empresas | Cargo | Inicio |
---|---|---|
LEGEND BIOTECH CORPORATION | Director Ejecutivo | 21/09/2020 |
Quanta Therapeutics, Inc.
![]() Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Director/Miembro de la Junta | 01/02/2022 |
Antiguos cargos conocidos de Ying Huang.
Empresas | Cargo | Fin |
---|---|---|
BofA Securities, Inc.
![]() BofA Securities, Inc. Investment Banks/BrokersFinance BofA Securities, Inc. is a registered broker-dealer subsidiary of NB Holdings Corp., ultimately held by Bank of America Corp. (NYSE: BAC). Headquartered in New York, the firm was founded in 2015 and offers trade execution, trading or brokerage services to institutional clients. | Corporate Officer/Principal | 01/07/2019 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
![]() Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Analyst-Equity | 13/05/2019 |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Barclays Capital, Inc.
![]() Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Analyst-Equity | 31/07/2014 |
Gleacher & Co. Securities, Inc.
![]() Gleacher & Co. Securities, Inc. Investment Banks/BrokersFinance Gleacher & Co. Securities, Inc. is an investment banking, capital markets and brokerage firm located in New York City. They are a subsidiary of Gleacher & Co., Inc. (NasdaqGM: GLCH). The firm was formerly known as Broadpoint Capital and was formed in 2010 as the result of the merger of merger of Broadpoint.Amtech Equity Capital Markets and Broadpoint.Gleacher Securities. Gleacher & Co. Securities provides corporate and public finance services and trading of corporate, government and municipal securities for institutional investors. The firm has three divisions: Municipal Capital Markets, Taxable Fixed-Income and Equity Capital Markets. The Municipal Capital Markets division underwrites and trades municipal securities in new issue and secondary markets. The Taxable Fixed-Income division is a broker/dealer that focuses on fixed-income securities with limited liquidity. The Equity Capital Markets division is a sector-focused investment banking group that provides research, trading, capital raising and advisory services to institutional and corporate clients. Gleacher & Co. Securities provides research on hundreds of equity, fixed-income and mortgage/asset backed securities. The firm offers research and execution services on thousands of securities across a full spectrum of industry sectors and asset classes. | Analyst-Equity | - |
Formación de Ying Huang.
The Trustees of Columbia University in The City of New York | Doctorate Degree |
University of Science & Technology of China | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
LEGEND BIOTECH CORPORATION | Health Technology |
Empresas privadas | 8 |
---|---|
Wachovia Securities LLC
![]() Wachovia Securities LLC Investment Banks/BrokersFinance Wachovia Securities LLC offered equity, fixed income, and structured products. It was founded in 2001 and was headquartered in St. Louis, MO. | Finance |
Credit Suisse Securities (USA) LLC (Broker)
![]() Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Finance |
Gleacher & Co. Securities, Inc.
![]() Gleacher & Co. Securities, Inc. Investment Banks/BrokersFinance Gleacher & Co. Securities, Inc. is an investment banking, capital markets and brokerage firm located in New York City. They are a subsidiary of Gleacher & Co., Inc. (NasdaqGM: GLCH). The firm was formerly known as Broadpoint Capital and was formed in 2010 as the result of the merger of merger of Broadpoint.Amtech Equity Capital Markets and Broadpoint.Gleacher Securities. Gleacher & Co. Securities provides corporate and public finance services and trading of corporate, government and municipal securities for institutional investors. The firm has three divisions: Municipal Capital Markets, Taxable Fixed-Income and Equity Capital Markets. The Municipal Capital Markets division underwrites and trades municipal securities in new issue and secondary markets. The Taxable Fixed-Income division is a broker/dealer that focuses on fixed-income securities with limited liquidity. The Equity Capital Markets division is a sector-focused investment banking group that provides research, trading, capital raising and advisory services to institutional and corporate clients. Gleacher & Co. Securities provides research on hundreds of equity, fixed-income and mortgage/asset backed securities. The firm offers research and execution services on thousands of securities across a full spectrum of industry sectors and asset classes. | Finance |
Barclays Capital, Inc.
![]() Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Finance |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
![]() Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Founded in 1958, Merrill Lynch Piece Fenner & Smith, Inc. is an SEC registered broker/dealer located in New York City. The firm is a subsidiary of BAC North America Holding Co. and their ultimate parent is Bank of America Corp. (NYSE BAC). | Finance |
BofA Securities, Inc.
![]() BofA Securities, Inc. Investment Banks/BrokersFinance BofA Securities, Inc. is a registered broker-dealer subsidiary of NB Holdings Corp., ultimately held by Bank of America Corp. (NYSE: BAC). Headquartered in New York, the firm was founded in 2015 and offers trade execution, trading or brokerage services to institutional clients. | Finance |
Quanta Therapeutics, Inc.
![]() Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Ying Huang